Investing, Biotechnology, Venture Capital, Science, Immune System.
clinic. The authors’ perspective highlights the potential of protein engineering to overcome the limitations of cytokine therapies for cancer treatment. By controlling the spatiotemporal aspects of cytokine signaling, exogenous cytokine therapies can more closely mimic their endogenous